VERONA PHARMA PLC - AMERICAN DEPOSITARY SHARES

Verona Pharma Announces June 2025 Investor Conference Participation

21 5月 2025 03:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025

06 5月 2025 03:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

29 4月 2025 03:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update

15 4月 2025 03:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS

28 3月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

27 2月 2025 03:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma Announces March 2025 Investor Conference Participation

18 2月 2025 03:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

13 2月 2025 03:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

07 1月 2025 03:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma Announces December 2024 Investor Conference Participation

18 11月 2024 23:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma to Present at Jefferies London Healthcare Conference

04 11月 2024 23:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

03 11月 2024 23:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

20 10月 2024 23:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024

29 9月 2024 23:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

04 9月 2024 23:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

07 8月 2024 23:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma to Present at 44th Annual Canaccord Growth Conference

29 7月 2024 23:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

24 7月 2024 23:00:00 条件 Nasdaq GlobeNewswire

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

26 6月 2024 13:57:26 条件 Nasdaq GlobeNewswire

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

09 5月 2024 04:15:00 条件 Nasdaq GlobeNewswire